Tuesday, May 5, 2026

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Surprising Facts About Wisdom Teeth You Didn’t Know

Wisdom teeth often emerge between 17 and 25. While extraction is common, only misaligned or impacted teeth usually need removal.

BTS’ ‘Butter’ Melts Records in Japan, Tops Oricon Chart

BTS has set another record in Japan. According...

Tag: chronic spontaneous urticaria

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

How is Omlyclo Revolutionizing Allergy Treatment in Europe: Key Successes and Insights

Celltrion's Omlyclo treatment is rapidly gaining market share in Europe, winning tenders and expanding prescriptions across multiple countries.

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Saving Poverty vs Free Trade Society? How Celltrion’s Biosimilar Could Reshape the U.S. Healthcare Market

Professor Metz highlights biosimilars' potential to expand patient access to treatments, emphasizing Omliclo's impact at EADV conference.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.